BioMatrix Infusion Pharmacy Expands Its Horizons
In a significant move aimed at enhancing patient care, BioMatrix Infusion Pharmacy has announced its acquisition of MyLyfe Health. This strategic decision is set to expand their service offerings into new regions, enhancing their capabilities in providing essential infusion services to patients in need.
Integration of Services
MyLyfe Health is recognized for its dedicated services in specialty pharmacy and home infusion, catering to individuals with chronic medical conditions. By combining resources, BioMatrix aims to merge its expertise with MyLyfe's, amplifying their outreach and strengthening their role in the infusion pharmacy market.
Enhancing Care for Patients
With MyLyfe Health under its umbrella, BioMatrix focuses on meeting the complex needs of its patients more efficiently. This acquisition not only enriches BioMatrix's portfolio but also promotes continued innovation within the field, ensuring improved access to medication through both home infusion and ambulatory centers.
A Commitment to Quality
“We are thrilled to welcome MyLyfe Health to the BioMatrix family,” expressed Ted Kramm, BioMatrix's Chief Executive Officer. “This acquisition aligns with our mission to provide high-quality, patient-centered care while expanding our footprint in the infusion pharmacy sector.” Kramm emphasized that the partnership will enhance both service quality and patient outcomes.
Shared Values and Mission
MyLyfe Health is distinguished for its patient-first philosophy, focusing on the well-being and enhanced quality of life for all its clients. Their clinical team is praised for ensuring the safe administration of infused therapies while fostering a compassionate environment. The synergy between BioMatrix and MyLyfe is expected to create a seamless transition for patients and healthcare providers alike.
Future Prospects
Mark Zatyrka, Founder and CEO of MyLyfe, remarked, “The combination of our two companies will allow us to further elevate infusion pharmacy services. We are excited about the opportunities ahead and are confident that this partnership will provide greater value to our patients and healthcare providers.” By leveraging each other's strengths, both organizations plan to cultivate a culture of excellence in patient care.
About BioMatrix Specialty Pharmacy
BioMatrix Specialty Infusion Pharmacy is an independent entity with significant experience in infusion pharmacy. As a trusted name within the industry, they are committed to delivering compassionate care while guiding patients through the complexities of treatment. With a focus on collaboration among patients, their families, and healthcare providers, they prioritize continuity of care and clinical success.
Contact Information
For more information, media inquiries can be directed to Tara Marchese, Senior Director of Marketing at BioMatrix Specialty Pharmacy. She can be reached via phone at 954-908-7636. BioMatrix is dedicated to making a difference in the lives of patients, ensuring they receive the highest quality of service and medical support.
Frequently Asked Questions
What services does BioMatrix Infusion Pharmacy offer?
BioMatrix provides home infusion and specialty pharmacy services to patients with chronic conditions, focusing on patient-centered care.
How does the acquisition improve patient care?
The acquisition of MyLyfe Health enhances BioMatrix’s ability to provide comprehensive infusion therapy and better access to medications.
Who is the CEO of BioMatrix Infusion Pharmacy?
Ted Kramm is the Chief Executive Officer of BioMatrix Infusion Pharmacy, steering the company toward growth and improved patient outcomes.
What distinguishes MyLyfe Health's approach?
MyLyfe Health emphasizes a patient-first philosophy, prioritizing individual needs and clinical safety in the administration of therapy.
How does the merger affect healthcare providers?
The combined expertise of both companies aims to streamline processes for healthcare providers, improving patient support and service delivery.
